Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Lenti-HPV-07 |
| Synonyms | |
| Therapy Description |
Lenti-HPV-07 is a lentiviral vector-based vaccine that encodes inactivated E6 and E7 antigens from HPV16 and HPV18, which potentially enhances immune response against HPV16 and HPV18-associated tumors and inhibits tumor growth (PMID: 37675835). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Lenti-HPV-07 | Lenti-HPV07|Lenti-HPV 07 | Lenti-HPV-07 is a lentiviral vector-based vaccine that encodes inactivated E6 and E7 antigens from HPV16 and HPV18, which potentially enhances immune response against HPV16 and HPV18-associated tumors and inhibits tumor growth (PMID: 37675835). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06319963 | Phase Ib/II | Lenti-HPV-07 | A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer | Recruiting | USA | 0 |